100
Participants
Start Date
October 25, 2023
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
RECRUITING
Abramson Cancer Center at University of Pennsylvania, Philadelphia
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Abramson Cancer Center at Penn Medicine
OTHER